2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- 9.23%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Shionogi & Co Lt (SGIOF)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 06/16/2026
Company Profile
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally. It is also involved in consumer healthcare business; manufacturing, sale, analytical testing, and pharmaceutical engineering of medicinal drugs and investigational drugs; contracted monitoring of epidemiological components in sewage; promotion of implementation in social infrastructure; and business related to providing data and information; develops and sells foothold; and research and development of mucosal vaccines. In addition, the company provides contract support services for experimental research; contract testing of agricultural production materials; solutions for education and healthcare, system development, human resource development, and training business; marketing support services; and IT services for medical and healthcare-related issues. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. The company was founded in 1878 and is headquartered in Kita, Japan.
Key Executives
- Isao Teshirogi
- Masashi Deguchi
- John Apeler Keller
- Akira Kato
- Takuji Fujiwara
Current Ownership Distribution
- Other802.7M (94.33%)
- Mutual Funds48.2M (5.67%)
- Institutions19,123 (0.002%)
- Insiders0 (0.00%)